HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 1 of 1
This Phase 2 clinical research study is evaluating the safety and effectiveness of a once-daily oral investigational medicine that may improve anemia and reduce the need for red blood cell (RBC) transfusions among some patients who are chronically transfused.
Related PI: Janet L. Kwiatkowski, MD, MSCE
Related Conditions: Sickle Cell Anemia, Sickle Cell Disease, Transfusion, Beta Thalassemia, Thalassemia